Extending the post thaw expiry of Moderna (Spikevax) COVID-19 vaccine in PCN designated sites

Ian Allen, Pharmacy Quality Assurance Regional Specialist (NW), North West Pharmaceutical Quality AssurancePublished Last updated See all updates

Extension of the post thaw expiry of Moderna (Spikevax) COVID-19 vaccine is no longer supported by Moderna.

Overview

Extension of the post thaw expiry of Spikevax® COVID-19 vaccine is no longer supported by Moderna.

Background

In February 2022, Moderna permitted certain thawed batches of Spikevax® to have their post-thaw expiry dates extended from 30 to 60 days. This permission is no longer applicable and so the SPS standard operating procedure supporting the process has been withdrawn.

All Spikevax® is supplied from the NHS’s logistics partners is already labelled with a 30-day post-thaw expiry date. No extensions may be applied.

Spikevax® stock which has already had a post-thaw expiry extension applied may be used until the extended expiry date.

Attachments

Other handling content for PCNs

Other COVID-19 vaccines resources

Change history

  1. Extension of the post thaw expiry of Spikevax® COVID-19 vaccine is no longer supported by Moderna
  1. Content reviewed and accurate
  1. First Published
  2. Published